Clinical Trial

Platelet Transfusion in Hematopoietic Transplantation

Study Description

Platelet Transfusion Requirements in Hematopoietic Transplantation

It is hypothesized that a strategy using prophylactic oral Tranexamic Acid (TXA) with therapeutic platelet transfusions is safe and effective compared to prophylactic platelet transfusions in patients undergoing an autologous hematopoietic stem cell transplantation (who are at risk for bleeding).

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Tranexamic Acid

Additional Information

Official Study Title

Platelet Transfusion Requirements in Hematopoietic Transplantation(PATH Pilot)

Clinical Trial ID

NCT02650791

ParticipAid ID

9aAWjd